Brightsurf Science News & Current Events

April 14, 2018
2018 AACR Annual Meeting presentations highlight the clinical utility of Bio-Rad's Droplet Digital PCR technology for discovering epigenetic biomarkers and measuring immunotherapy response
Researchers showcase how droplet digital PCR technology can be used to identify epigenetic biomarkers to determine cancer recurrence after surgery and measure circulating tumor DNA for immunotherapy response.

Updates on new therapies in development for rare liver diseases
Long-term data with sebelipase alfa for lysosomal acid lipase deficiency and preliminary data for investigational RNAi therapeutics for acute intermittent porphyria and alpha-1 antitrypsin deficiency add continued hope for the future management of metabolic and rare liver diseases.

Fecal microbiota transplantation produces sustained improvements in cognitive and clinical outcomes
Long-term results of a randomized study demonstrate sustained improvements in hepatic encephalopathy episodes, hospitalizations, and cognitive performance compared with standard-of-care.

Hepatitis C: Simplified curative treatments can drive global scale-up
According to a WHO progress report, an estimated 1.5 million people started direct-acting antiviral (DAA) treatment in 2016, compared to around 1 million in 2015.1 Behind the impressive scale-up seen in 2016, a diverse set of countries have been leading the action.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.